Keywords: Actavis, Watson Pharma, Global name, Financial forecasts, Dr Reddy's, Clarinex Reditabs, US launch

Watson Pharma now trading as Actavis; Dr Reddy's debuts generic Clarinex Reditabs in USA

Article | 28 January 2013

Print This

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) announced last week that the company has adopted Actavis Inc as its new ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in